Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Geroldi

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Cardiologia (Rome, Italy)|February 1, 1987
[Protective effect of glutathione against changes in Ca2+ transport in vesicles of the sarcoplasmic reticulum of the heart induced by oxidative stress]G Bellomo, V Marinoni, A Salis, et al.
Journal of Cardiovascular Risk|November 17, 1998
Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphismC Gazzaruso, A Garzaniti, P Buscaglia, et al.
Journal of the American College of Cardiology|February 6, 1999
Association between apolipoprotein(a) phenotypes and coronary heart disease at a young ageC Gazzaruso, A Garzaniti, P Buscaglia, et al.
Haematologica|March 1, 1987
Immunologic status, granulocyte chemotaxis and antibodies to HTLVIII/LAV in haemophiliacs treated with clotting factor concentratesG Gamba, G Ippoliti, G Bajani, et al.
Annals of Internal Medicine|August 1, 1985
No hepatitis after treatment with a modified factor IX concentrate in previously untreated hemophiliacsP M Mannucci, M Morfini, L Gatti, et al.
Journal of Cardiovascular Risk|April 1, 1996
Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertensionC Gazzaruso, P Buscaglia, A Garzaniti, et al.
Journal of Hypertension|March 1, 1997
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertensionC Gazzaruso, P Buscaglia, A Garzaniti, et al.
International Journal of Cardiology|September 6, 2003
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery diseaseC Falcone, L Nespoli, D Geroldi, et al.
European Journal of Clinical Investigation|April 20, 2006
Markers of eosinophilic inflammation and risk prediction in patients with coronary artery diseaseC Falcone, P Minoretti, A D'Angelo, et al.
Acta Diabetologica|June 13, 1998
Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complicationsC Gazzaruso, A Garzaniti, P Buscaglia, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Cardiologia (Rome, Italy)|February 1, 1987
[Protective effect of glutathione against changes in Ca2+ transport in vesicles of the sarcoplasmic reticulum of the heart induced by oxidative stress]G Bellomo, V Marinoni, A Salis, et al.
Journal of Cardiovascular Risk|November 17, 1998
Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphismC Gazzaruso, A Garzaniti, P Buscaglia, et al.
Journal of the American College of Cardiology|February 6, 1999
Association between apolipoprotein(a) phenotypes and coronary heart disease at a young ageC Gazzaruso, A Garzaniti, P Buscaglia, et al.
Haematologica|March 1, 1987
Immunologic status, granulocyte chemotaxis and antibodies to HTLVIII/LAV in haemophiliacs treated with clotting factor concentratesG Gamba, G Ippoliti, G Bajani, et al.
Annals of Internal Medicine|August 1, 1985
No hepatitis after treatment with a modified factor IX concentrate in previously untreated hemophiliacsP M Mannucci, M Morfini, L Gatti, et al.
Journal of Cardiovascular Risk|April 1, 1996
Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertensionC Gazzaruso, P Buscaglia, A Garzaniti, et al.
Journal of Hypertension|March 1, 1997
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertensionC Gazzaruso, P Buscaglia, A Garzaniti, et al.
International Journal of Cardiology|September 6, 2003
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery diseaseC Falcone, L Nespoli, D Geroldi, et al.
European Journal of Clinical Investigation|April 20, 2006
Markers of eosinophilic inflammation and risk prediction in patients with coronary artery diseaseC Falcone, P Minoretti, A D'Angelo, et al.
Acta Diabetologica|June 13, 1998
Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complicationsC Gazzaruso, A Garzaniti, P Buscaglia, et al.
Pageof 5